aminocaproic acid has been researched along with Heart Valve Diseases in 4 studies
Aminocaproic Acid: An antifibrinolytic agent that acts by inhibiting plasminogen activators which have fibrinolytic properties.
6-aminohexanoic acid : An epsilon-amino acid comprising hexanoic acid carrying an amino substituent at position C-6. Used to control postoperative bleeding, and to treat overdose effects of the thrombolytic agents streptokinase and tissue plasminogen activator.
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ray, MJ | 2 |
| Hales, M | 1 |
| Marsh, N | 1 |
| Hales, MM | 1 |
| Brown, L | 1 |
| O'Brien, MF | 1 |
| Stafford, EG | 1 |
| Trinh-Duc, P | 1 |
| Wintrebert, P | 1 |
| Boulfroy, D | 1 |
| Albat, B | 1 |
| Thévenet, A | 1 |
| Roquefeuil, B | 1 |
| Mikunis, RI | 1 |
| Salobaĭ, VA | 1 |
3 trials available for aminocaproic acid and Heart Valve Diseases
| Article | Year |
|---|---|
Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
Topics: alpha-2-Antiplasmin; Aminocaproic Acid; Antifibrinolytic Agents; Aprotinin; Cardiopulmonary Bypass; | 2001 |
Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
Topics: Aged; Aminocaproic Acid; Aprotinin; Cardiopulmonary Bypass; Coronary Artery Bypass; Coronary Disease | 2001 |
[Comparison of the effects of epsilon-aminocaproic acid and aprotinin on intra- and postoperative bleeding in heart surgery].
Topics: Aminocaproic Acid; Aprotinin; Blood Loss, Surgical; Coronary Artery Bypass; Female; Heart Septal Def | 1992 |
1 other study available for aminocaproic acid and Heart Valve Diseases
| Article | Year |
|---|---|
[Dynamics of the kallikrein-kinin system in patients with recurrent rheumatic carditis associated with heart defects after administration of inhibitors of the kallikrein-kinin system in complex antirheumatic therapy].
Topics: Adult; Aminocaproic Acid; Aprotinin; Female; Heart Valve Diseases; Humans; Kallikreins; Kinins; Male | 1986 |